Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership4,499,724 shares
Latest Disclosed Value $ 20,248,758
D. E. Shaw & Co., Inc. ownership in MYGN / Myriad Genetics, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 4,499,724 shares of Myriad Genetics, Inc. (US:MYGN) valued at $20,248,758 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 4,505,193 shares of Myriad Genetics, Inc.. This represents a change in shares of -0.12% during the quarter. The current value of the position is $19,798,786 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (MYGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MYGN / Myriad Genetics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MYRIAD GENETICS COM 62855J104 4,499,724 -5,469 -0.12 20,249 -26.92 0.0122
2026-02-17 2025-12-31 13F MYRIAD GENETICS COM 62855J104 4,505,193 -53,943 -1.18 27,707 -15.95 0.0152
2025-11-14 2025-09-30 13F MYRIAD GENETICS COM 62855J104 4,559,136 47,639 1.06 32,963 37.59 0.0186
2025-08-14 2025-06-30 13F MYRIAD GENETICS COM 62855J104 4,511,497 1,988,879 78.84 23,956 7.07 0.0170
2025-05-15 2025-03-31 13F MYRIAD GENETICS COM 62855J104 2,522,618 702,804 38.62 22,376 -10.32 0.0199
2025-02-14 2024-12-31 13F MYRIAD GENETICS COM 62855J104 1,819,814 668,429 58.05 24,950 -20.89 0.0183
2024-11-14 2024-09-30 13F MYRIAD GENETICS COM 62855J104 1,151,385 24,638 2.19 31,536 14.43 0.0271
2024-08-14 2024-06-30 13F MYRIAD GENETICS COM 62855J104 1,126,747 -139,366 -11.01 27,560 2.10 0.0258
2024-05-15 2024-03-31 13F MYRIAD GENETICS COM 62855J104 1,266,113 -535,193 -29.71 26,994 -21.70 0.0231
2024-02-14 2023-12-31 13F MYRIAD GENETICS COM 62855J104 1,801,306 -376,619 -17.29 34,477 -1.31 0.0301
2023-11-14 2023-09-30 13F MYRIAD GENETICS COM 62855J104 2,177,925 150,903 7.44 34,934 -25.65 0.0365
2023-08-14 2023-06-30 13F MYRIAD GENETICS COM 62855J104 2,027,022 44,697 2.25 46,986 2.03 0.0480
2023-05-15 2023-03-31 13F MYRIAD GENETICS COM 62855J104 1,982,325 125,025 6.73 46,049 70.87 0.0493
2023-02-14 2022-12-31 13F MYRIAD GENETICS COM 62855J104 1,857,300 100,834 5.74 26,949 -19.59 0.0298
2022-11-14 2022-09-30 13F MYRIAD GENETICS COM 62855J104 1,756,466 -284,394 -13.94 33,513 -9.62 0.0400
2022-08-15 2022-06-30 13F MYRIAD GENETICS COM 62855J104 2,040,860 154,286 8.18 37,082 -22.00 0.0435
2022-05-16 2022-03-31 13F MYRIAD GENETICS COM 62855J104 1,886,574 -21,030 -1.10 47,542 -9.70 0.0445
2022-02-14 2021-12-31 13F MYRIAD GENETICS COM 62855J104 1,907,604 -101,258 -5.04 52,650 -18.83 0.0437
2021-11-15 2021-09-30 13F MYRIAD GENETICS COM 62855J104 2,008,862 -233,807 -10.43 64,866 -5.42 0.0585
2021-08-16 2021-06-30 13F MYRIAD GENETICS COM 62855J104 2,242,669 -417,038 -15.68 68,581 -15.32 0.0592
2021-05-17 2021-03-31 13F MYRIAD GENETICS COM 62855J104 2,659,707 -555,742 -17.28 80,988 27.37 0.0782
2021-02-16 2020-12-31 13F MYRIAD GENETICS COM 62855J104 3,215,449 -197,964 -5.80 63,585 42.86 0.0569
2020-11-16 2020-09-30 13F MYRIAD GENETICS COM 62855J104 3,413,413 124,083 3.77 44,510 19.33 0.0456
2020-08-14 2020-06-30 13F MYRIAD GENETICS COM 62855J104 3,289,330 609,172 22.73 37,301 -2.74 0.0444
2020-05-15 2020-03-31 13F MYRIAD GENETICS COM 62855J104 2,680,158 -188,256 -6.56 38,353 -50.90 0.0598
2020-02-14 2019-12-31 13F MYRIAD GENETICS COM 62855J104 2,868,414 364,645 14.56 78,107 8.96 0.0893
2019-11-14 2019-09-30 13F MYRIAD GENETICS COM 62855J104 2,503,769 -819,327 -24.66 71,683 -22.35 0.0883
2019-08-14 2019-06-30 13F MYRIAD GENETICS COM 62855J104 3,323,096 -523,346 -13.61 92,315 -27.71 0.1151
2019-05-15 2019-03-31 13F MYRIAD GENETICS COM 62855J104 3,846,442 -76,410 -1.95 127,702 11.98 0.1650
2019-02-14 2018-12-31 13F MYRIAD GENETICS COM 62855J104 3,922,852 29,874 0.77 114,037 -36.32 0.1571
2018-11-14 2018-09-30 13F MYRIAD GENETICS COM 62855J104 3,892,978 -157,755 -3.89 179,077 18.30 0.2151
2018-08-14 2018-06-30 13F MYRIAD GENETICS COM 62855J104 4,050,733 -132,682 -3.17 151,376 22.45 0.1975
2018-05-15 2018-03-31 13F MYRIAD GENETICS COM 62855J104 4,183,415 -573,174 -12.05 123,620 -24.33 0.1683
2018-02-14 2017-12-31 13F MYRIAD GENETICS COM 62855J104 4,756,589 -109,314 -2.25 163,365 -7.20 0.2250
2017-11-14 2017-09-30 13F MYRIAD GENETICS COM 62855J104 4,865,903 85,792 1.79 176,048 42.53 0.2705
2017-08-14 2017-06-30 13F MYRIAD GENETICS COM 62855J104 4,780,111 582,862 13.89 123,518 53.27 0.2043
2017-05-15 2017-03-31 13F MYRIAD GENETICS COM 62855J104 4,197,249 1,427,127 51.52 80,588 74.52 0.1417
2017-02-14 2016-12-31 13F MYRIAD GENETICS COM 62855J104 2,770,122 546,837 24.60 46,178 0.92 0.0784
2016-11-14 2016-09-30 13F MYRIAD GENETICS COM 62855J104 2,223,285 -681,192 -23.45 45,755 -48.52 0.0807
2016-08-15 2016-06-30 13F MYRIAD GENETICS COM 62855J104 2,904,477 -23,667 -0.81 88,877 -18.91 0.1639
2016-05-16 2016-03-31 13F MYRIAD GENETICS COM 62855J104 2,928,144 448,985 18.11 109,601 2.43 0.1967
2016-02-16 2015-12-31 13F MYRIAD GENETICS COM 62855J104 2,479,159 401,917 19.35 107,000 37.43 0.1593
2015-11-16 2015-09-30 13F MYRIAD GENETICS COM 62855J104 2,077,242 486,307 30.57 77,855 43.97 0.1147
2015-08-14 2015-06-30 13F MYRIAD GENETICS COM 62855J104 1,590,935 138,426 9.53 54,076 5.17 0.0806
2015-05-15 2015-03-31 13F MYRIAD GENETICS COM 62855J104 1,452,509 -69,650 -4.58 51,419 -0.82 0.0788
2015-02-17 2014-12-31 13F MYRIAD GENETICS COM 62855J104 1,522,159 13,856 0.92 51,844 -10.88 0.0667
2014-11-14 2014-09-30 13F MYRIAD GENETICS COM 62855J104 1,508,303 710,396 89.03 58,175 87.33 0.0753
2014-08-14 2014-06-30 13F MYRIAD GENETICS COM 62855J104 797,907 720,540 931.33 31,055 1,074.10 0.0423
2014-05-15 2014-03-31 13F MYRIAD GENETICS COM 62855J104 77,367 -244,313 -75.95 2,645 -60.81 0.0038
2014-02-14 2013-12-31 13F MYRIAD GENETICS COM 62855J104 321,680 84,978 35.90 6,749 21.34 0.0092
2013-11-20 2013-09-30 13F/A-1 MYRIAD GENETICS COM 62855J104 236,702 -948,399 -80.03 5,562 -82.53 0.0089
2013-11-14 2013-09-30 13F MYRIAD GENETICS COM 62855J104 236,702 5,562
2013-08-14 2013-06-30 13F MYRIAD GENETICS COM 62855J104 1,185,101 1,185,101 31,844 0.0599
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-05-15 2018-03-31 13F MYRIAD GENETICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F MYRIAD GENETICS COM Call 7,300 251 n/a n/a n/a
2017-11-14 2017-09-30 13F MYRIAD GENETICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F MYRIAD GENETICS COM Call 32,400 0.00 837 34.57 n/a n/a n/a
2017-05-15 2017-03-31 13F MYRIAD GENETICS COM Call 32,400 622 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-11-14 2017-09-30 13F MYRIAD GENETICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F MYRIAD GENETICS COM Put 19,600 -3.92 506 29.08 n/a n/a n/a
2017-05-15 2017-03-31 13F MYRIAD GENETICS COM Put 20,400 392 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.